BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2859878)

  • 21. Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine.
    Lahti RA; Sethy VH; Barsuhn C; Hester JB
    Neuropharmacology; 1983 Nov; 22(11):1277-82. PubMed ID: 6320036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isopropyl substitution on barbiturate ring: effects on 'open field' and 'hole board' behaviour and on biogenic amines concentrations in discrete regions of the rat brain after acute and chronic administration.
    Ménez JF; Leonard BE
    Neuropsychobiology; 1986; 15(2):95-100. PubMed ID: 3762905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The olfactory bulbectomized rat as a model of depression.
    Leonard BE
    Pol J Pharmacol Pharm; 1984; 36(5):561-9. PubMed ID: 6099892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chronic administration of the 6-aza analogue of mianserin (Org. 3770) and its enantiomers on behaviour and changes in noradrenaline metabolism of olfactory-bulbectomized rats in the "open field" apparatus.
    O'Connor WT; Leonard BE
    Neuropharmacology; 1986 Mar; 25(3):267-70. PubMed ID: 3703175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alprazolam in a biochemical model of depression.
    Sethy VH; Hodges DH
    Biochem Pharmacol; 1982 Oct; 31(19):3155-7. PubMed ID: 6128981
    [No Abstract]   [Full Text] [Related]  

  • 26. Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety.
    Johnston AL; File SE
    Psychiatry Res; 1988 Jul; 25(1):81-90. PubMed ID: 3217470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepam.
    DeVane CL; Ware MR; Lydiard RB
    Psychopharmacol Bull; 1991; 27(4):463-73. PubMed ID: 1687613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine-induced increases in open-field habituation in the olfactory bulbectomized rat depend on test aversiveness but not on anxiety.
    Mar A; Spreekmeester E; Rochford J
    Pharmacol Biochem Behav; 2002 Oct; 73(3):703-12. PubMed ID: 12151047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative studies on antidepressant action of alprazolam in different animal models.
    Kostowski W; Malatyńska E; Płaźnik A; Dyr W; Danysz W
    Pol J Pharmacol Pharm; 1986; 38(5-6):471-81. PubMed ID: 2883637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzodiazepines as antidepressants: does GABA play a role in depression?
    Petty F; Trivedi MH; Fulton M; Rush AJ
    Biol Psychiatry; 1995 Nov; 38(9):578-91. PubMed ID: 8573660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The discriminative stimulus effects of diazepam in rats at two training doses.
    Tang AH; Franklin SR
    J Pharmacol Exp Ther; 1991 Sep; 258(3):926-31. PubMed ID: 1679851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triazolobenzodiazepines antagonize the effects of anxiogenic drugs mediated at three different central nervous system sites.
    File SE; Pellow S
    Neurosci Lett; 1985 Oct; 61(1-2):115-9. PubMed ID: 2867497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of triazolo-benzodiazepine and benzodiazepine action in anxiety and depression: behavioral studies with concomitant in vivo CA1 hippocampal norepinephrine and serotonin release detection in the behaving animal.
    Broderick PA; Hope O; Jeannot P
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Feb; 22(2):353-86. PubMed ID: 9608607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment.
    Connor TJ; Harkin A; Kelly JP; Leonard BE
    Neuroimmunomodulation; 2000; 7(1):27-35. PubMed ID: 10601816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alprazolam modifies animal behaviour on elevated plus-maze.
    Kulkarni SK; Sharma K
    Indian J Exp Biol; 1993 Nov; 31(11):908-11. PubMed ID: 7906673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The determination of the optimal dose of milnacipran in the olfactory bulbectomized rat model of depression.
    Redmond AM; Kelly JP; Leonard BE
    Pharmacol Biochem Behav; 1999 Apr; 62(4):619-23. PubMed ID: 10208367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. U-43,465F: a triazolobenzodiazepine with pronounced antidepressant-like as well as anxiolytic activities in animals.
    Von Voigtlander PF; Puech AJ
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):60-76. PubMed ID: 6141773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats.
    Wierońska JM; Papp M; Pilc A
    Pol J Pharmacol; 2001; 53(5):517-25. PubMed ID: 11990071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adinazolam both prevents and reverses the long-term reduction of daily activity produced by inescapable shock.
    Maier SF; Silbert LH; Woodmansee WW; Desan PH
    Pharmacol Biochem Behav; 1990 Aug; 36(4):767-73. PubMed ID: 2217504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative metabolism of limbic structures after acute administration of diazepam, alprazolam and zolpidem.
    González-Pardo H; Conejo NM; Arias JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1020-6. PubMed ID: 16647177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.